Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01213940 · ClinicalTrials.gov registry record · NA
Vascular Endothelium Changes After Bariatric Surgery (Endothelial Progenitor Cells)
A NA study, sponsored by University of South Alabama.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01213940: Completed NA study, sponsored by University of South Alabama.
NCT01213940 is a NA study that has completed, run by University of South Alabama. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01213940, a NA study, has completed, sponsored by University of South Alabama.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Improvement in cardiovascular mortality is related to changes in pathologic autoantibodies and in the number of circulating functional replicative competent endothelial progenitor cells (EPC's) after bariatric surgery.
Interventions
- BEHAVIORAL pre-bariatric weight loss program
- PROCEDURE bariatric surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01213940
The ClinicalTrials.gov registry entry for NCT01213940 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Alabama, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which pre-bariatric weight loss program is the first listed.
NCT01213940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01213940 about?
NCT01213940 is a clinical study titled "Vascular Endothelium Changes After Bariatric Surgery (Endothelial Progenitor Cells)". Improvement in cardiovascular mortality is related to changes in pathologic autoantibodies and in the number of circulating functional replicative competent endothelial progenitor cells (EPC's) after bariatric surgery.
What is the current status of trial NCT01213940?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-09. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01213940?
The interventions under investigation include: pre-bariatric weight loss program (BEHAVIORAL), bariatric surgery (PROCEDURE).
Who is sponsoring clinical trial NCT01213940?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.